The Hidden Risk: Cardio-metabolic Health in Women

Written By Retha Howard

Many women are managing fatigue, weight changes, irregular cycles, or elevated blood pressure long before anyone names what’s really happening.

They’re often told:
“Your labs are normal.”
“Just work on diet and exercise.”

Yet something still feels off.

What’s often being missed is the early development of cardiometabolic risk,

a pattern that connects metabolic health, hormones, and long-term cardiovascular outcomes.

What Is Cardio-metabolic Risk?

Cardiometabolic risk refers to a group of interconnected factors that increase the likelihood of:

  • cardiovascular disease

  • type 2 diabetes

  • stroke

These risks are often driven by:

  • insulin resistance

  • lipid abnormalities (↑ triglycerides, ↓ HDL)

  • central weight gain

  • elevated blood pressure

  • chronic inflammation

According to the American Heart Association, these factors rarely occur in isolation and often progress silently over time.

Why This Matters for Women

Cardiovascular disease is the leading cause of death in women, yet early signs are often subtle.

Instead of classic symptoms, women may experience:

  • persistent fatigue

  • difficulty losing weight

  • irregular cycles

  • worsening PMS

  • brain fog

These symptoms are frequently dismissed, when they may reflect early metabolic dysfunction.

A Missing Piece: Your Pregnancy History

Pregnancy is not separate from your long-term health—it can reveal early signs of cardiometabolic risk.

Complications such as:

  • preeclampsia or gestational hypertension

  • gestational diabetes

  • preterm delivery

are now recognized as early indicators of future cardiovascular and metabolic disease.

Research shows:

  • Women with a history of preeclampsia have a 2–4× higher risk of developing hypertension and cardiovascular disease later in life

  • Gestational diabetes significantly increases the risk of developing type 2 diabetes within 5–10 years postpartum

Despite this, many women are not followed long-term after pregnancy.

These patterns are often missed.

What Research Continues to Show

  • Insulin resistance plays a central role in both metabolic and cardiovascular disease (ADA Standards of Care)

  • Metabolic syndrome significantly increases long-term cardiovascular risk (NCEP ATP III)

  • Chronic inflammation contributes to vascular dysfunction and disease progression

  • Women with conditions like PCOS have increased cardiometabolic risk (Endocrine Society)

Clinical guidelines now emphasize early identification—even before disease is diagnosed.

The Gap in Care

Too often, symptoms are treated individually:

  • weight → diet advice

  • cycles → birth control

  • fatigue → basic labs

But these concerns are often connected.

Without recognizing the pattern, early risk is overlooked.

Why I Developed a Cardio-metabolic Assessment Tool

In my clinical experience, I began to notice a pattern:

Women presenting with:

  • metabolic changes

  • hormonal symptoms

  • subtle cardiovascular indicators

…without a clear, unified evaluation.

So I developed a Cardiometabolic Assessment Tool to:

  • identify early patterns of risk

  • evaluate metabolic, hormonal, and cardiovascular health together

  • guide more intentional, personalized care

Why Early Detection Matters

Early identification creates an opportunity to intervene.

Evidence shows that early intervention can:

  • improve insulin sensitivity

  • reduce progression to type 2 diabetes

  • lower cardiovascular risk

The Diabetes Prevention Program demonstrated up to a 58% reduction in progression to diabetes with early lifestyle intervention.

Not everything is inevitable—especially when recognized early.

What This Means for You

If you’ve been experiencing:

  • fatigue

  • unexplained weight changes

  • irregular cycles

  • “normal labs” but persistent symptoms

…it may be time to look beyond isolated results and evaluate the full picture.

Next Steps

If you’re navigating these concerns and want a more complete evaluation:

You can begin with a consultation to explore your symptoms and labs in more detail.

For more focused concerns, Essential Care visits may also be appropriate.

Clinical References

  • American Heart Association (AHA). Cardiovascular Disease in Women

  • American Diabetes Association (ADA). Standards of Care in Diabetes, 2024

  • American College of Obstetricians and Gynecologists (ACOG). Optimizing Postpartum Care

  • Endocrine Society. PCOS Clinical Practice Guidelines

  • NCEP ATP III. Metabolic Syndrome Criteria

  • Knowler WC, et al. Diabetes Prevention Program, NEJM (2002)

  • Brown MC, et al. Preeclampsia and Future Cardiovascular Risk

  • Wu P, et al. Long-term Cardiovascular Outcomes After Preeclampsia

Retha Howard https://www.rawluvorganix.com